SCHEMBL3369447

SCHEMBL3369447

O=C(O[I+](c1ccc2ccc(=O)oc2c1)c1ccc2oc3ccccc3c(=O)c2c1)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TTR P02766 2/20 0.37
MAOA P21397 4/20 0.37
NPC1 O15118 4/20 0.36
RAB9A P51151 3/20 0.36
KMT2A Q03164 2/20 0.35
MEN1 O00255 1/20 0.35
POLB P06746 2/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
ACSL1 P33121 4/20 0.34
ACSL6 Q9UKU0 3/20 0.34
ACSL3 O95573 1/20 0.33
CASP3 P42574 1/20 0.33
SENP8 Q96LD8 1/20 0.33
SENP7 Q9BQF6 1/20 0.33
SENP6 Q9GZR1 1/20 0.33
CA12 O43570 2/20 0.33
CA9 Q16790 2/20 0.33
TBK1 Q9UHD2 1/20 0.33
KDM4E B2RXH2 2/20 0.33
ALDH1A1 P00352 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3371686 1.00 TTR (0.37) TTRMAOANPC1RAB9AKMT2A
SCHEMBL3520753 0.92 TTR (0.43) TTRMAOANPC1RAB9AKMT2A
SCHEMBL3525243 0.92 TTR (0.43) TTRMAOANPC1RAB9AKMT2A
SCHEMBL3367834 0.87 CA9 (0.39) KMT2AMEN1POLBL3MBTL1CA12
SCHEMBL3521814 0.87 CA9 (0.39) KMT2AMEN1POLBL3MBTL1CA12
SCHEMBL3365946 0.82 NPC1 (0.35) TTRMAOANPC1RAB9AKMT2A
SCHEMBL3367496 0.81 NPC1 (0.48) TTRMAOANPC1RAB9AKMT2A
SCHEMBL3371703 0.81 NPC1 (0.36) TTRMAOANPC1RAB9AKMT2A
SCHEMBL3367716 0.77 NPC1 (0.40) TTRMAOANPC1RAB9AKMT2A
SCHEMBL3369444 0.75 TTR (0.38) TTRMAOANPC1RAB9AKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7833691-B2 Heterocycle-bearing onium salts WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) 2010-11-16 US disclosed
EP-1953149-B1 A heterocycle-containing onium salt WAKO PURE CHEM IND LTD (JP) 2010-10-06 EP disclosed
EP-1953149-A2 A heterocycle-containing onium salt Wako Pure Chemical Industries, Ltd. (JP) 2008-08-06 EP disclosed
US-20080161520-A1 Heterocycle-bearing onium salts WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) 2008-07-03 US disclosed
US-7318991-B2 Diphenylsulfonium compounds in which the S atom is additionally attached to a xanthene-9-onyl-2-yl- or coumarin-7-yl- ring; acid generator for a chemically amplified resist; photopolymerization initiator for polymerizing an epoxide or a vinyl ether WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) 2008-01-15 US disclosed
US-20050233253-A1 Diphenylsulfonium compounds in which the S atom is additionally attached to a xanthene-9-onyl-2-yl- or coumarin-7-yl- ring; acid generator for a chemically amplified resist; photopolymerization initiator for polymerizing an epoxide or a vinyl ether WAKO PURE CHEMICAL INDUSTRIES, LTD (JP) 2005-10-20 US disclosed
EP-1481973-A1 HETEROCYCLE-BEARING ONIUM SALTS Wako Pure Chemical Industries, Ltd. (JP) 2004-12-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050233253-A1 Diphenylsulfonium compounds in which the S atom is additionally attached to a xanthene-9-onyl-2-yl- or coumarin-7-yl- ring; acid generator for a chemically amplified resist; photopolymerization initiator for polymerizing an epoxide or a vinyl ether NOX4, CBR1, CBR3 TTR 4812/4885MAOA 1663/4885NPC1 3094/4885
US-20080161520-A1 Heterocycle-bearing onium salts MCM5, NIT2, PCNA TTR 4638/4885MAOA 1429/4885NPC1 4804/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.